An interventional study of colposcopy and cervical Papanicolaou test in Cervical Intraepithelial Neoplasia Grade 1, Cervical Intraepithelial Neoplasia Grade 2 and Cervical Intraepithelial Neoplasia Grade 3, sponsored by Northwestern University. Withdrawn. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-06-11.
Sponsored by Northwestern University · Not applicable, Interventional, and Screening
This clinical trial studies colposcopy and high resolution anoscopy in screening for anal dysplasia in patients with cervical, vaginal, or vulvar dysplasia or cancer. Screening may help doctors find cancer cells early and plan better treatment for cancer
OBJECTIVES:
I. To evaluate the risk of anal dysplasia in women with cervical or vulvar dysplasia.
OUTLINE:
Patients undergo colposcopy and cervical Papanicolaou test with Human papillomavirus (HPV) test followed by anal Papanicolaou test and high resolution anoscopy. Patients with dysplastic anal lesions undergo repeat anoscopy at 3, 9, 15, and 24 months. Patients with normal anoscopy are followed up at 1 and 2 years.
1,881 studies on the registry are indexed under Uterine Cervical Neoplasms; 567 are open to participants now.
Browse Uterine Cervical Neoplasms studies →Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.
Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
See Detailed Description
Procedure: colposcopy · Other: cervical Papanicolaou test · Procedure: screening method
Undergo colposcopy
Undergo cervical Pap smear
Also known as: cervical Pap test
Undergo anal Pap smear
Undergo high resolution anoscopy
Risk of anal dysplasia in women with cervical or vulvar dysplasia
Time frame: Over 2 years
HPV (Human Papillomavirus) status
Time frame: Over 2 years
No study locations are listed for this record.
This study is withdrawn, as verified in Jun 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Northwestern University